善水科技(301190.SZ):IPO定價為27.85元/股 12月15日申購
格隆匯12月13日丨善水科技(301190.SZ)公佈次公開發行股票並在創業板上市發行公吿,、發行人和保薦機構(主承銷商)中原證券根據初步詢價結果,綜合考慮剩餘報價及擬申購數量、發行人所處行業、市場情況、同行業上市公司估值水平、募集資金需求及承銷風險等因素,協商確定本次發行價格為27.85元/股,網下發行不再進行累計投標詢價。
投資者請按此價格在2021年12月15日(T日)進行網上和網下申購,申購時無需繳付申購資金。本次網下發行申購日與網上申購日同為2021年12月15日(T日),其中,網下申購時間為9:30-15:00,網上申購時間為9:15-11:30,13:00-15:00。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.